Global $983 Million Transient Protein Expression Market Forecast to 2027 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Transient Protein Expression Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product Type; Application; End User, and Geography." report has been added to ResearchAndMarkets.com's offering.

Growing Adoption of Precision Medicines to Drive Transient Protein Expression Market

The global transient protein expression market is expected to reach US$ 983.10 million by 2027 from US$ 660.00 million in 2019. The market is estimated to grow at a CAGR of 5.3% from 2020 to 2027.

Based on product type, the transient protein expression market is segmented into instruments, reagents, vectors, and competent cells. In 2019, the instruments segment held the largest market share. This segment is also expected to dominate the market during the forecast period as instruments are reducing human input which enables continuous cell maintenance and protein production. Moreover, the same segment is anticipated to grow at the fastest rate during the forecast period.

Driving factors, such as increasing applications of protein expression and growing adoption of precision medicines, are expected to boost the market growth over the years. However, high cost of products is likely to pose a negative impact on the market growth.

The coronavirus pandemic is estimated to have significant impact on the transient protein expression market. Majority of the pharmaceutical companies around the globe are engaged in the development of vaccines for coronavirus. However, this shift of focus is anticipated to have a negative impact on the other segments of the market. Also, disruptions in supply chain caused due to halt in global operations are projected to have an adverse impact on the market.

Prominent players operating in transient protein expression market include THERMO FISHER SCIENTIFIC INC.; MERCK KGaA; QIAGEN; GenScript; Promega Corporation; Takara Bio Inc.; MERIDIAN BIOSCIENCE, INC.; New England Biolabs; Agilent Technologies, Inc.; Mirus Bio LLC; and Sino Biological Inc.

Key Topics Covered:

1. Introduction

1.1 Scope of the Study

1.2 Report Guidance

1.3 Market Segmentation

2. Transient Protein Expression Market - Key Takeaways

3. Research Methodology

4. Transient Protein Expression Market - Market Landscape

4.1 Overview

4.2 PEST Analysis

4.4 Expert Opinion

5. Transient Protein Expression Market - Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Applications of Protein Expression

5.1.2 Growing Adoption of Precision Medicines

5.2 Market Restraints

5.2.1 High Cost of Products

5.3 Market Opportunities

5.3.1 Therapeutic Protein Production by Transient Protein Expression in Plants

5.4 Future Trends

5.4.1 Growing Traction Toward Recombinant Proteins

5.5 Impact Analysis

6. Transient Protein Expression Market - Global Analysis

6.1 Global Transient Protein Expression Market Revenue Forecast And Analysis

6.2 Global Transient Protein Expression Market, By Geography - Forecast And Analysis

6.3 Market Positioning

7. Transient Protein Expression Market - By Product Type

7.1 Overview

7.2 Transient Protein Expression Market Share, by Product Type, 2019 and 2027 (%)

7.3 Instruments

7.3.1 Overview

7.3.2 Instruments: Transient Protein Expression Market - Revenue and Forecast to 2027 (USD Million)

7.3.3 Automated Transient Protein Expression Systems

7.3.4 Manual Transient Protein Expression Systems

7.4 Reagents

7.5 Expression Vectors

7.6 Competent Cells

8. Transient Protein Expression Market - By Application

8.1 Overview

8.2 Transient Protein Expression Market Share, by Application, 2019 and 2027 (%)

8.3 Genomic Research

8.4 Gene Therapy

8.5 Bio Production

8.6 Cancer Research

8.7 Drug Development

9. Transient Protein Expression Market - By End User

9.1 Overview

9.2 Transient Protein Expression Market Share, by End User, 2019 and 2027 (%)

9.3 Pharmaceutical and Biotechnology Companies

9.4 Academic and Research Institutes

9.5 Clinical Research Organizations

10. Transient Protein Expression Market - Geographic Analysis

11. Impact of COVID-19 Pandemic on Global Transient Protein Expression Market

11.1 North America: Impact Assessment of COVID-19 Pandemic

11.2 Europe: Impact Assessment of COVID-19 Pandemic

11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic

11.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

12. Transient Protein Expression Market - Industry Landscape

12.1 Overview

12.2 Growth Strategies Done by the Companies in the Market, (%)

12.3 Organic Developments

12.3.1 Overview

12.4 Inorganic Developments

12.4.1 Overview

13. Company Profiles

Thermo Fisher Scientific Inc.

Merck Kgaa Qiagen Genscript Promega Corporation Takara Bio Inc. Meridian Bioscience, Inc. New England Biolabs Agilent Technologies, Inc. Mirus Bio Llc Sino Biological Inc.

For more information about this report visit https://www.researchandmarkets.com/r/z0f1r4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900